1. Report Overview

1.1 The Drug Discovery Outsourcing Market Overview

1.2 Drug Discovery Outsourcing Market Segmentation

1.3 Why You Should Read This Report

1.4 How This Report Delivers

1.5 Key Questions Answered by This Analytical Report

1.6 Who is This Report For?

1.7 Methodology

1.8 Frequently Asked Questions (FAQ)

1.9 Associated Reports

2. An Introduction to Drug Discovery Outsourcing

2.1 What is Outsourcing?

2.2 What is Drug Discovery Outsourcing?

2.3 Why Outsource Drug Discovery?

2.4 A Common Drug Discovery Model Includes Pharmaceutical Organizations Collaborating with Academia

2.5 The Outsource Model for Drug Development Increases Innovation

2.6 Outsourced Processes in Drug Discovery

2.7 Challenges with Drug Discovery Outsourcing

2.8 Emerging Markets are a Popular Destination for CROs

2.9 Strategic Partnerships to Acquisitions

2.10 Recent Drug Development Outsourcing Agreements

2.11 Glossary of Terms Related to Drug Discovery Outsourcing

3. Global Drug Discovery Outsourcing Market and Service Area Submarkets, 2016-2026

3.1 Drug Discovery Outsourcing: Global Market Overview

3.2 The Global Drug Discovery Outsourcing Market Sectors

3.3 The Global Drug Discovery Outsourcing Market by Sector, 2015

3.4 The Global Drug Discovery Outsourcing Market by Sector, 2015-2026

3.5 The Changing Market Shares by Sector, 2015-2026

3.6 The Global Chemistry Services Outsourcing Market, 2015

3.6.1 Libraries

3.6.2 Building Blocks

3.6.3 Compound Synthesis

3.6.4 The Global Chemistry Services Outsourcing Market Forecast, 2015-2026

3.7 The Global Biology Services Outsourcing Market, 2015

3.7.1 Target Identification

3.7.2 Target Validation

3.7.3 The Global Biology Services Outsourcing Market Forecast, 2015-2026

3.8 The Global Lead Optimisation Market, 2015

3.8.1 ADMET Screening: Prevents Late Stage Failure of Clinical Trials

3.8.2 The Global Lead Optimisation Market Forecast, 2015-2026

3.9 The Global Lead Identification and Screening Outsourcing Market, 2015

3.9.1 Methods of Screening in Drug Discovery

3.9.2 Primary Screening

3.9.3 The Global Lead Identification and Screening Outsourcing Market Forecast, 2015-2026

4. The Leading National Markets in the Drug Discovery Outsourcing Market 2015-2026

4.1 Drug Discovery Outsourcing Overview

4.2 The Leading National Markets in the Drug Discovery Outsourcing Market, 2015

4.3 The Leading National Markets in the Drug Discovery Outsourcing Market, 2015-2026

4.4 The Changing Market Shares of the Leading National Markets in the Drug Discovery Outsourcing Market, 2015-2026

4.5 CAGRs of the Leading National Markets in the Drug Discovery Outsourcing Market, 2015-2026

4.6 The US Drug Discovery Outsourcing Market Sales Forecast, 2015-2026

4.7 The EU5 Drug Discovery Outsourcing Market by Region, 2015

4.7.1 The EU5 Drug Discovery Outsourcing Market Forecast, 2015-2026

4.7.2 CAGRs by EU5 Region, 2015-2026

4.7.3 The EU5 Changing Market Shares by Country 2015-2026

4.7.3.1 The German Drug Discovery Outsourcing Market Sales Forecast, 2015-2026

4.7.3.2 The UK Drug Discovery Outsourcing Market Sales Forecast, 2015-2026

4.7.3.3 The French Drug Discovery Outsourcing Market Sales Forecast, 2015-2026

4.7.3.4 The Italian Drug Discovery Outsourcing Market Sales Forecast, 2015-2026

4.7.3.5 The Spanish Drug Discovery Outsourcing Market Sales Forecast, 2015-2026

4.8 The Japanese Drug Discovery Outsourcing Market Sales Forecast, 2015-2026

4.9 The Chinese Drug Discovery Outsourcing Market Sales Forecast, 2015-2026

4.9.1 Challenges to China’s Growth

4.10 The Indian Drug Discovery Outsourcing Market Sales Forecast, 2015-2026

4.11 The Brazilian Drug Discovery Outsourcing Market Sales Forecast, 2015-2026

4.12 The Russian Drug Discovery Outsourcing Market Sales Forecast, 2015-2026

4.13 The South Korean Drug Discovery Outsourcing Market Sales Forecast, 2015-2026

4.14 The Mexican Drug Discovery Outsourcing Market Sales Forecast, 2015-2026

4.15 The Rest of the World Drug Discovery Outsourcing Market Sales Forecast, 2015-2026

5. Leading Companies in the Drug Discovery Outsourcing Market

5.1 Drug Discovery Outsourcing: A Fragmented and Growing Marketplace

5.2 Characteristics of Leading Contract Research Organisations

5.2.1 A Highly Quality Workforce

5.2.2 Emphasis on Intellectual Property Protection

5.2.3 Long Term Working Relationship

5.2.4 Success in Project Completion

5.2.5 Internal Drug Discovery Programmes

5.3 Service Offerings of Leading Companies in the Drug Discovery Outsourcing Market

5.4 Albany Molecular Research (AMRI)

5.4.1 Historical Sales and Recent Financial Performance, 2011-2014

5.4.2 AMRI’s Drug Discovery Services

5.4.3 Internal Portfolio of Drug Discovery and Development Programme Collaborations

5.4.4 AMRI (DDS) Sales Forecast, 2015-2026

5.5 Aptuit

5.5.1 INDIGO: Accelerating Early Drug Candidates

5.5.2 Aptuit Clinical Trial Supplies

5.5.3 Strategic Partnerships, Acquisitions and Divestitures

5.5.3.1 Divestiture of Aseptic Clinical Manufacturing

5.5.3.2 Aptuit’s Extended Partnership with GSK for VeronaCentre

5.5.3.3 Partnership with Siena Biotech

5.5.3.4 Partnership with Laurus Labs

5.6 Charles River Laboratories

5.6.1 Sales and Historical Financial Performance, 2011-2014

5.6.2 Charles River Laboratories: An External Acquisition Strategy

5.6.2.1 Acquisition of ChanTest

5.6.2.2 Acquisition of Galapagos’ CRO Services Division (BioFocus and Argenta)

5.6.2.3 Acquisition of VivoPath

5.6.3 Charles River Laboratories: Revenue and Financial Analysis, 2014

5.6.3.1 Charles River Laboratories: Historical Financial Performance by Business Segment, 2013-2014

5.6.4 Charles River Laboratories Sales Forecast, 2015-2026

5.7 Covance (Acquired by Laboratory Corporation of America)

5.7.1 Covance: Historical Revenue and Financial Performance, 2010-2013

5.7.2 Covance: Early Stage Discovery Efforts

5.7.3 Agreement with Sanofi

5.7.4 Agreement with Kellogg Company

5.7.5 Agreement with Bio Pontis Alliance

5.7.6 Agreement with Indiana Clinical and Translational Sciences Institute (CTSI)

5.7.7 Agreement with EliLilly

5.8 Cyprotex

5.8.1 Historical Revenue and Financial Performance, 2011-2014

5.8.2 Cyprotex: Revenue by Region, 2015

5.8.3 Cyprotex: Revenue Analysis and Forecast 2015-2026

5.9 Domainex

5.9.1 Drug Pipeline

5.9.2 TBK1/ IKKεInhibitors

5.9.3 Methyltransferase (KMTS) Inhibitors

5.10 Evotec

5.10.1 Strategic Action Plan

5.10.2 Evotec: Historical Revenue and Financial Analysis, 2010-2014

5.10.3 EVT Integrate and EVT Innovate

5.10.4 Partnerships with Pharma for Drug Discovery

5.10.4.1 Partnership with Sanofi

5.10.4.2 Extended Partnership with Evotec

5.10.4.3 Partnership with Johnson & Johnson

5.10.4.4 Partnership with AstraZeneca

5.10.4.5 Partnership with Bayer Pharmaceuticals

5.10.4.6 Partnership with Boehringer Ingelheim Pharma

5.10.4.7 Collaboration with CHDI

5.10.4.8 Collaboration with Janssen

5.10.4.9 Collaboration with MedImmune

5.10.4.10 Collaboration with UCBPharma

5.10.5 Evotec Sales Forecast, 2015-2026

5.11 GenScript

5.11.1 GenScript: Agreements and Partnerships

5.12 Pharmaceutical Product Development (PPD)

5.12.1 PPD: Agreements, Strategic Partnerships and Private Merger

5.12.1.1 Acquisition of Acurian

5.12.1.2 Partnership with Elan

5.12.1.3 Partnership with GSK

5.13 Quintiles

5.13.1 Quintiles: Historical Revenue and Financial Performance, 2009-2014

5.13.2 Development Deal With Merck

5.13.3 Quintiles: Acquisition of Advion Bioanalytical Labs

5.13.4 Quintiles: SheddingJobs

5.13.5 Quintiles Sales Forecast, 2015-2026

5.14 Selcia

5.14.1 A Strong Natural Product Chemistry Track Record

5.14.2 Initiative with the University of Edinburgh

5.14.3 Collaboration with Cantab

5.15 Viva Biotech

5.15.1 GPCR Targeted Discovery Programs

5.15.2 Antibody Therapeutics Discovery

5.16 WIL Research Laboratories

5.16.1 Focus on Preclinical Research

5.16.2 Acquisition of Ricerca Biosciences LLC

5.16.3 Acquisition of Midwest Bio Research

5.17 WuXi Apptec

5.17.1 WuXi AppTec: Service Offerings

5.17.2 Acquisition of Next CODE Health

5.17.3 WuXiAppTec: Historical Revenue and Financial Performance, 2010-2014

5.17.4 WuXiAppTec: Laboratory Services Sales Forecast, 2015-2026

6. Quantitative Analysis of the Drug Discovery Outsourcing Market, 2016-2026

6.1 Drivers and Restraints in the Drug Discovery Outsourcing Market, 2016-2026

6.2 SWOT Analysis of the Drug Discovery Outsourcing Market, 2016-2026

6.3 Strengths

6.3.1 Cost Reduction: A Central Driver for Outsourcing

6.3.2 Accelerating the Discovery of Drug Candidates

6.3.3 Growth of Virtual Pharmaceutical Companies

6.3.4 Reduction in R&D capacity Within Big Pharma

6.4 Weaknesses

6.4.1 Slowing Trajectory of Growth for R&D Spending

6.4.2 Increasingly Saturated Market Requires Companies to Quickly Evolve

6.5 Opportunities

6.5.1 The Available Scope for the Expansion of CROs

6.5.2 Targeted Therapies: Advances in Biologics and Orphan Drugs

6.5.3 Increasing Development of Biologics and Biosimilars

6.6 Threats

6.6.1 A Competitive Market is Increasing Consolidation

6.6.2 Threat of Private Public Alliances

6.6.3 Intellectual Property Leaks

6.6.4 Challenges of Technology Transfer

6.7 Porter’s Five Force Analysis of the Drug Discovery Outsourcing Market

6.7.1 Threat of New Entrants: Medium

6.7.2 Power of Suppliers: Medium

6.7.3 Threat of Substitutes: Medium

6.7.4 Power of Buyers: High

6.7.5 Rivalry Among Competitors: High

7. Expert Opinions

7.1 Interview with Dr. Mario Polywka, Chief Operating Officer, Evotec

7.1.1 Bridging the Gap Between Academia and BigPharma

7.1.2 Evotec: Specialises in Certain Disease Therapies

7.1.3 Complete Drug Discovery Outsourcing: A Growing Trend

7.1.4 Strategies for Drug Discovery Outsourcing Expansion

7.1.5 Building Trust in Collaborations

7.1.6 Evotec: Proven Track Record of Success

7.2 Dr. John Davis, Director of Discovery and Dave Roberts, Business Development Director, Radiochemistry, Selcia

7.2.1 Growth in the Full Spectrum of Outsourcing Services

7.2.2 Natural Products: Increasing Source of Drug Discovery

7.2.3 Strong Pool of Early Drug Candidates

7.2.4 Overcoming Drug Discovery Challenges using Drug Discovery

7.2.5 Selcia: Regional Base of Clients

7.2.6 Drug Discovery and Emerging Technologies

7.2.7 Med Chem Plus Projects

7.2.8 Varied Customer Base

7.2.9 CROs: Improving Drug Discovery Productivity Levels?

7.3 Interview with Dr. Paul Overton, Executive VP, Business Development & Marketing, Aptuit

7.3.1 End-to-End Drug Discovery Integration Growth

7.3.2 Whole Project Externalisation

7.3.3 Drug Discovery Outsourcing: One of Aptuit’s Fastest Growing Services

7.3.4 Aptuit INDiGO® Program

7.3.5 Aptuit Implementation Drug Discovery Acquisitions

7.3.6 Aptuit: Adding the Intellectual Capabilities for Drug Discovery

7.3.7 Several Partners in the Drug Discovery Model

8. Conclusion

8.1 Market Overview

8.2 Lead Optimisation will be the Fastest Growing Sector

8.3 The Drug Discovery Outsourcing Market in Emerging Market Shows Huge Gains

8.4 Continued Growth in Alliances and Collaborations

8.5 Concluding Remarks

AssociatedVisiongainReports

VisiongainReportSalesOrderForm

AppendixA

AboutVisiongain

AppendixB

Visiongain report evaluation form

List of Tables

Table 1.1 The Drug Discovery Outsourcing Market Forecast: Revenue ($bn), AGR (%), CAGR (%), 2015-2026

Table 1.2 The Indian Drug Discovery Outsourcing Market Forecast: Revenue ($bn), AGR (%), CAGR (%), 2015-2026

Table 2.1 Indication of Functions Outsourced in the Different Stages of the Drug R&D Process, 2016

Table 2.2 Selected Drug Discovery Outsourcing Alliances, 2013-2016

Table 2.2 (Cont’d) Selected Drug Discovery Outsourcing Alliances, 2013-2016

Table 3.1 PhMRA’s Historical Estimate for its Member’s Total R&D Spending ($bn), 1980-2015

Table 3.2 The Global Drug Discovery Outsourcing Market: Revenue ($bn), Market Share (%) by Sector, 2015

Table 3.3 The Global Drug Discovery Outsourcing Market Forecast: Revenue ($bn), AGR (%), CAGR (%) by Sector, 2015-2026

Table 3.4 The Global Drug Discovery Outsourcing Market: Revenue Share (%) by Sector, 2015 , 2020 and 2026

Table 3.5 The Chemistry Services Outsourcing Market Forecast: Revenue ($bn), AGR (%), CAGR (%) by Sector, 2015-2026

Table 3.6 The Biology Services Outsourcing Market Forecast: Revenue ($bn), AGR (%), CAGR (%) by Sector, 2015-2026

Table 3.7 The Lead Optimisation Outsourcing Market Forecast: Revenue ($bn), AGR (%), CAGR (%) by Sector, 2015-2026

Table 3.8 Selected Source for Lead Compounds, 2015

Table 3.9 The Lead Identification and Screening Outsourcing Market Forecast: Revenue ($bn), AGR (%), CAGR (%), 2015-2026

Table 4.1 The Global Drug Discovery Outsourcing Market: Revenue ($bn), Market Share (%) by Region, 2015

Table 4.2 The Global Drug Discovery Outsourcing Market Forecast: Revenue ($bn), AGR (%), CAGR (%) by Region, 2015-2026

Table 4.2.1 The Global Drug Discovery Outsourcing Market Forecast: Revenue ($bn), AGR (%), CAGR (%) by Region, 2015-2026

Table 4.3 The Global Drug Discovery Outsourcing Market: Market Share (%) by Region, 2015, 2020, 2026

Table 4.4 The Global Drug Discovery Outsourcing Market Forecast: CAGR (%) by Region, 2015-2020, 2020-2026, 2015-2026

Table 4.5 The US Drug Discovery Outsourcing Market Forecast: Revenue ($bn), AGR (%), CAGR (%), 2015-2026

Table 4.6 The US Drug Discovery Outsourcing Market Forecast: Market Size ($bn), Rank, Market Share (%) and CAGR (%), 2015-2026

Table 4.7 The EU5 Drug Discovery Outsourcing Market: Revenue ($bn), Market Share (%) by Region, 2015

Table 4.8 The EU5 Drug Discovery Outsourcing Market Forecast: Revenue ($bn), AGR (%), CAGR (%), 2015-2026

Table 4.9 The EU5 Drug Discovery Outsourcing Market Forecast: CAGR (%) by Country, 2015-2020, 2020-2026, and 2015-2026

Table 4.10 The EU5 Drug Discovery Outsourcing Market: Market Shares (%) by Country, 2015, 2020, 2026

Table 4.11 The German Drug Discovery Outsourcing Market Forecast: Revenue ($bn), AGR (%), CAGR (%), 2015-2026

Table 4.12 The German Drug Discovery Outsourcing Market Forecast: Market Size ($bn), Rank, Market Share (%) and CAGR (%), 2015-2026

Table 4.13 The UK Drug Discovery Outsourcing Market Forecast: Revenue ($bn), AGR (%), CAGR (%), 2015-2026

Table 4.14 The UK Drug Discovery Outsourcing Market Forecast: Market Size ($bn), Rank, Market Share (%) and CAGR (%), 2015-2026

Table 4.15 The French Drug Discovery Outsourcing Market Forecast: Revenue ($bn), AGR (%), CAGR (%), 2015-2026

Table 4.16 The French Drug Discovery Outsourcing Market Forecast: Market Size ($bn), Rank, Market Share (%) and CAGR (%), 2015-2026

Table 4.17 The Italian Drug Discovery Outsourcing Market Forecast: Revenue ($bn), AGR (%), CAGR (%), 2015-2026

Table 4.18 The Italian Drug Discovery Outsourcing Market Forecast: Market Size ($bn), Rank, Market Share (%) and CAGR (%), 2015-2026

Table 4.19 The Spanish Drug Discovery Outsourcing Market Forecast: Revenue ($bn), AGR (%), CAGR (%), 2015-2026

Table 4.20 The Spanish Drug Discovery Outsourcing Market Forecast: Market Size ($bn), Rank, Market Share (%) and CAGR (%), 2015-2026

Table 4.21 The Japanese Drug Discovery Outsourcing Market Forecast: Revenue ($bn), AGR (%), CAGR (%), 2015-2026

Table 4.22 The Japanese Drug Discovery Outsourcing Market Forecast: Market Size ($bn), Rank, Market Share (%) and CAGR (%), 2015-2026

Table 4.23 The Chinese Drug Discovery Outsourcing Market Forecast: Revenue ($bn), AGR (%), CAGR (%), 2015-2026

Table 4.24 The Chinese Drug Discovery Outsourcing Market Forecast: Market Size ($bn), Rank, Market Share (%) and CAGR (%), 2015-2026

Table 4.25 The Indian Drug Discovery Outsourcing Market Forecast: Revenue ($bn), AGR (%), CAGR (%), 2015-2026

Table 4.26 The Indian Drug Discovery Outsourcing Market Forecast: Market Size ($bn), Rank, Market Share (%) and CAGR (%), 2015-2026

Table 4.27 The Brazilian Drug Discovery Outsourcing Market Forecast: Revenue ($bn), AGR (%), CAGR (%), 2015-2026

Table 4.28 The Brazilian Drug Discovery Outsourcing Market Forecast: Market Size ($bn), Rank, Market Share (%) and CAGR (%), 2015-2026

Table 4.29 The Russian Drug Discovery Outsourcing Market Forecast: Revenue ($bn), AGR (%), CAGR (%), 2015-2026

Table 4.30 The Russian Drug Discovery Outsourcing Market Forecast: Market Size ($bn), Rank, Market Share (%) and CAGR (%), 2015-2026

Table 4.31 The South Korean Drug Discovery Outsourcing MarketForecast: Revenue ($bn), AGR (%), CAGR (%), 2015-2026

Table 4.32 The South Korean Drug Discovery Outsourcing Market Forecast: Market Size ($bn), Rank, Market Share (%) and CAGR (%), 2015-2026

Table 4.33 The Mexican Drug Discovery Outsourcing Market Forecast: Revenue ($bn), AGR (%), CAGR (%), 2015-2026

Table 4.34 The Mexican Drug Discovery Outsourcing Market Forecast: Market Size ($bn), Rank, Market Share (%) and CAGR (%), 2015-2026

Table 4.35 The Rest of the World Drug Discovery Outsourcing Market Forecast: Revenue ($bn), AGR (%), CAGR (%), 2015-2026

Table 5.1 Albany Molecular Research (AMRI): Historical Revenue ($m), 2011-2014

Table 5.2 AMRI: Service Offerings and Descriptions, 2015

Table 5.3 AMRI: Drug Discovery and Development Programmes and Project Stage, 2015

Table 5.4 AMRI (DDS) Forecast: Revenue ($m), AGR (%), CAGR (%), 2015-2026

Table 5.5 Aptuit: Services Offered and their Descriptions, 2015

Table 5.6 Charles River Laboratories: Services Offered by Segment, 2016

Table 5.7 Charles River Laboratories: Revenue ($m), AGR (%), 2011-2014

Table 5.8 Charles River Laboratories: Revenue ($m) by Segment, 2011-2014

Table 5.9 Charles River Laboratories: Revenue ($bn) by Business Segment, 2013-2014

Table 5.10 Charles River Laboratories Forecast: Revenue ($m), AGR (%), CAGR (%), 2015-2026

Table 5.11 Covance: Historical Revenue ($bn) by Business Segment, 2010-2013

Table 5.12 Selected Cyprotex Partnerships, 2015

Table 5.13 Cyprotex: Historical Revenue ($m), (£m), AGR (%), 2011-2014

Table 5.14 Cyprotex: Revenue ($m), Revenue Share (%) by Region, 2015

Table 5.15 Cyprotex Forecast: Revenue ($m), AGR (%), CAGR (%), 2015-2026

Table 5.16 Cyprotex Selected Collaborations

Table 5.17 Evotec: Historical Revenue ($m), 2010-2014

Table 5.18 Evotec: Discovery Pipeline, 2016

Table 5.19 Evotec Forecast: Revenue ($m), AGR (%), CAGR (%), 2015-2026

Table 5.20 GenScript: Services Offered and Descriptions, 2015

Table 5.21 Quintiles: Revenue ($bn), AGR (%), 2009-2014

Table 5.22 Quintiles Forecast: Revenue ($bn), AGR (%), CAGR (%), 2015-2026

Table 5.23 Selcia: Drug Discovery Services Portfolio, 2015

Table 5.24 VivaBiotech: Service Offerings, 2015

Table 5.25 WuXiAppTec: Pharmaceutical Laboratory Services and Descriptions, 2016

Table 5.26 WuXiAppTec: Historical Revenue ($m), AGR (%) by Business Segment, 2010-2014

Table 5.27 WuXiAppTec Laboratory Services Forecast: Revenue ($m), AGR (%), CAGR (%), 2015-2026

Table 6.1 SWOT Analysis of the Drug Discovery Outsourcing Industry, 2016-2026

Table 8.1 The Global Drug Discovery Outsourcing Market Forecast:

Revenue ($bn), CAGR (%), 2015, 2020, 2026

Table 8.2 The Global Drug Discovery Outsourcing Market: Revenue ($bn) by Sector, 2015, 2020, 2026

Table 8.3 The Drug Discovery Outsourcing Market Forecast: Revenue ($bn) by Emerging Market, 2015, 2020 and 2026

List of Figures

Figure 1.1 The Drug Discovery Outsourcing Market: Overview of Submarkets

Figure 2.1Selected Tasks being Outsourced in the Pharma Industry, 2016

Figure 2.2 Stages of the Drug Development Cycle

Figure 3.1 PhMRA’s Historical Estimate for its Member’s Total R&D Spending ($bn), 1980-2015

Figure 3.2 Attrition Rate of Compounds at the Developmental Stages

Figure 3.3 The Global Drug Discovery Outsourcing Market: Revenue ($bn) by Sector, 2015

Figure 3.4 The Global Drug Discovery Outsourcing Market: Market Share (%) by Sector, 2015

Figure 3.5 The Global Drug Discovery Outsourcing Market Forecast: Revenue ($bn), AGR (%), 2015-2026

Figure 3.6 The Global Drug Discovery Outsourcing Market: Market Shares (%) by Sector, 2020

Figure 3.7 The Global Drug Discovery Outsourcing Market: Market Shares (%)by Sector, 2026

Figure 3.8 The Chemistry Services Outsourcing Market Forecast: Revenue ($bn), AGR (%), 2015-2026

Figure 3.9 The Biology Services Outsourcing Market Forecast: Revenue ($bn), AGR (%), 2015-2026

Figure 3.10 An Overview of ADMET Screening in Drug Discovery

Figure 3.11 The Lead Optimisation Outsourcing Market Forecast: Revenue ($bn), AGR (%), 2015-2026

Figure 3.12 Typical Steps in the Lead Screening Process

Figure 3.13 The Lead Identification and Screening Outsourcing Market a Forecast: Revenue ($bn), AGR (%), 2015-2026

Figure 4.1 The Global Drug Discovery Outsourcing Market: Revenue ($bn) by Region, 2015

Figure 4.2 The Global Drug Discovery Outsourcing Market: Market Share (%) by Region, 2015

Figure 4.3 The Global Drug Discovery Outsourcing Market: Market Share (%) by Region, 2020

Figure 4.4 The Global Drug Discovery Outsourcing Market: Market Share (%) by Region, 2026

Figure 4.5 The Global Drug Discovery Outsourcing Market Forecast: CAGR (%) by Region, 2015-2020

Figure 4.6 The Global Drug Discovery Outsourcing Market Forecast: CAGR (%) by Region, 2020-2026

Figure 4.7 The Global Drug Discovery Outsourcing Market Forecast: CAGR (%) by Region, 2015-2026

Figure 4.8 The US Drug Discovery Outsourcing Market Forecast: Revenue ($bn), AGR (%), 2015-2026

Figure 4.9 The EU5 Drug Discovery Outsourcing Market: Market Revenue ($bn) by EU5 Country, 2015

Figure 4.10 The EU5 Drug Discovery Outsourcing Market: Market Share (%) by Region, 2015

Figure 4.11 The EU5 Drug Discovery Outsourcing Market Forecast: Revenue ($bn), AGR (%), 2015-2026

Figure 4.12 The EU5 Drug Discovery Outsourcing Market Forecast: CAGR (%) by Country, 2015-2020

Figure 4.13 The EU5 Drug Discovery Outsourcing Market Forecast: CAGR (%) by Country, 2020-2026

Figure 4.14 The EU5 Drug Discovery Outsourcing Market Forecast: CAGR (%) by Country, 2015-2026

Figure 4.15 The EU5 Drug Discovery Outsourcing Market Forecast: Market Shares (%) by Country, 2020

Figure 4.16 The EU5 Drug Discovery Outsourcing Market Forecast: Market Shares (%) by Country, 2026

Figure 4.17 The German Drug Discovery Outsourcing Market Forecast: Revenue ($bn), AGR (%), 2015-2026

Figure 4.18 The UK Drug Discovery Outsourcing Market Forecast: Revenue ($bn), AGR (%), 2015-2026

Figure 4.19 The French Drug Discovery Outsourcing Market Forecast: Revenue ($bn), AGR (%), 2015-2026

Figure 4.20 The Italian Drug Discovery Outsourcing Market Forecast: Revenue ($m), AGR (%), 2015-2026

Figure 4.21 The Spanish Drug Discovery Outsourcing Market Forecast: Revenue ($bn), AGR (%), 2015-2026

Figure 4.22 The Japanese Drug Discovery Outsourcing Market Forecast: Revenue ($bn), AGR (%), 2015-2026

Figure 4.23 The Chinese Drug Discovery Outsourcing Market Forecast: Revenue ($bn), AGR (%), 2015-2026

Figure 4.24 The Chinese Population Demographics: Over 65 population and Forecast (millions) , 1950, 2010, 2050

Figure 4.25 The Indian Drug Discovery Outsourcing Market Forecast: Revenue ($bn), AGR (%), 2015-2026

Figure 4.26 The Brazilian Drug Discovery Outsourcing Market Forecast: Revenue ($bn), AGR (%), 2015-2026

Figure 4.27 The Russian Drug Discovery Outsourcing Market Forecast: Revenue ($bn), AGR (%), 2015-2026

Figure 4.28 The South Korean Drug Discovery Outsourcing Market Forecast: Revenue ($bn), AGR (%), 2015-2026

Figure 4.29 The Mexican Drug Discovery Outsourcing Market Forecast: Revenue ($bn), AGR (%), 2015-2026

Figure 4.30 The Rest of the World Drug Discovery Outsourcing Market Forecast: Revenue ($bn), AGR (%), 2015-2026

Figure 5.1 Albany Molecular Research (AMRI): Historical Revenue ($m), 2011-2014

Figure 5.2 AMRI (DDS) Forecast: Revenue ($m), AGR (%), 2015-2026

Figure 5.3 Charles River Laboratories: Revenue ($m), AGR (%), 2011-2014

Figure 5.4 Charles River Laboratories: Revenue Share (%) by Segment, 2014

Figure 5.5 Charles River Laboratories: Revenue ($bn), 2013-2014

Figure 5.6 Charles River Laboratories: Revenue Share (%) by Business Segment, 2014

Figure 5.7 Charles River Laboratories Forecast: Revenue ($m), AGR (%), 2015-2026

Figure 5.8 Covance: Historical Revenue ($bn), 2010-2013

Figure 5.9 Covance: Revenue Share (%) by Segment, 2013

Figure 5.10 Cyprotex: Historical Revenue ($m), AGR (%), 2011-2014

Figure 5.11 Cyprotex: Revenue Share(%) by Region, 2015

Figure 5.12 Cyprotex Forecast: Revenue ($m), AGR (%), 2015-2026

Figure 5.13 Domainex: Drug Pipeline by Indication, 2015

Figure 5.14 Evotec: Historical Revenue ($m) 2010-2014

Figure 5.15 Evotec Forecast: Revenue ($m), AGR (%), 2015-2026

Figure 5.16 Quintiles: Historical Revenue ($bn), AGR (%), 2009-2014

Figure 5.17 Quintiles Forecast: Revenue ($bn), AGR (%), 2015-2026

Figure 5.18 WuXiAppTec: Historical Revenue ($m) for Laboratory Services, 2010-2014

Figure 5.19 WuXiAppTec Laboratory Services Forecast: Revenue ($m), AGR (%), 2015-2026

Figure 6.1 The Drug Discovery Outsourcing Market: Drivers and Restraints, 2016-2026

Figure 6.2 Porter’s Five Analysis of the Companion Diagnostics Market, 2016-2026

Figure 8.1 The Global Drug Discovery Outsourcing Market Forecast: Revenue ($bn), 2015, 2020, 2026

Figure 8.2 The Global Drug Discovery Outsourcing Market Forecast: Revenue ($bn) by Sector, 2015, 2020, 2026

Figure 8.3 The Drug Discovery Outsourcing Market Forecast: Revenue ($bn) by Emerging Market, 2015, 2020 and 2026